{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:46:37Z","timestamp":1793317597428,"version":"4.5.0"},"reference-count":53,"publisher":"American Association for Cancer Research (AACR)","issue":"11","funder":[{"name":"HHS | NIH | National Cancer InstituteHHS | NIH | National Cancer Institute (NCI)","award":["R37CA232209"],"award-info":[{"award-number":["R37CA232209"]}]},{"name":"HHS | NIH | National Cancer InstituteHHS | NIH | National Cancer Institute (NCI)","award":["R37CA232209"],"award-info":[{"award-number":["R37CA232209"]}]},{"name":"HHS | NIH | National Cancer InstituteHHS | NIH | National Cancer Institute (NCI)","award":["R37CA232209"],"award-info":[{"award-number":["R37CA232209"]}]},{"name":"HHS | NIH | National Cancer InstituteHHS | NIH | National Cancer Institute (NCI)","award":["R37CA232209"],"award-info":[{"award-number":["R37CA232209"]}]},{"name":"NSF | MPS | Division of Mathematical SciencesNSF | MPS | Division of Mathematical Sciences (DMS)","award":["DMS-1462049"],"award-info":[{"award-number":["DMS-1462049"]}]},{"name":"Pennsylvania Department of HealthPennsylvania Department of Health (PDH)","award":["SAP 4100062224"],"award-info":[{"award-number":["SAP 4100062224"]}]},{"name":"DOD | Congressionally Directed Medical Research ProgramsDOD | Congressionally Directed Medical Research Programs (CDMRP)","award":["BC032981,BC044784,W81XWH-12-1-0415,BC132245_W81XWH-14-0258"],"award-info":[{"award-number":["BC032981,BC044784,W81XWH-12-1-0415,BC132245_W81XWH-14-0258"]}]},{"name":"University of PittsburghUniversity of Pittsburgh (Pitt)","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}]},{"name":"University of Pittsburgh Cancer InstituteUniversity of Pittsburgh Cancer Institute (UPCI)","award":["CCSG P30CA047904"],"award-info":[{"award-number":["CCSG P30CA047904"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Targeting microenvironmental factors that foster migratory cell phenotypes is a promising strategy for halting tumor migration. However, lack of mechanistic understanding of the emergence of migratory phenotypes impedes pharmaceutical drug development. Using our three-dimensional microtumor model with tight control over tumor size, we recapitulated the tumor size\u2013induced hypoxic microenvironment and emergence of migratory phenotypes in microtumors from epithelial breast cells and patient-derived primary metastatic breast cancer cells, mesothelioma cells, and lung cancer xenograft cells. The microtumor models from various patient-derived tumor cells and patient-derived xenograft cells revealed upregulation of tumor-secreted factors, including matrix metalloproteinase-9 (MMP9), fibronectin (FN), and soluble E-cadherin, consistent with clinically reported elevated levels of FN and MMP9 in patient breast tumors compared with healthy mammary glands. Secreted factors in the conditioned media of large microtumors induced a migratory phenotype in nonhypoxic, nonmigratory small microtumors. Subsequent mathematical analyses identified a two-stage microtumor progression and migration mechanism whereby hypoxia induces a migratory phenotype in the initialization stage, which then becomes self-sustained through a positive feedback loop established among the tumor-secreted factors. Computational and experimental studies showed that inhibition of tumor-secreted factors effectively halts microtumor migration despite tumor-to-tumor variation in migration kinetics, while inhibition of hypoxia is effective only within a time window and is compromised by tumor-to-tumor variation, supporting our notion that hypoxia initiates migratory phenotypes but does not sustain it. In summary, we show that targeting temporal dynamics of evolving microenvironments, especially tumor-secreted factors during tumor progression, can halt tumor migration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study uses state-of-the-art three-dimensional microtumor models and computational approaches to highlight the temporal dynamics of tumor-secreted microenvironmental factors in inducing tumor migration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-18-3151","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T14:26:44Z","timestamp":1554474404000},"page":"2962-2977","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Targeting the Temporal Dynamics of Hypoxia-Induced Tumor-Secreted Factors Halts Tumor Migration"],"prefix":"10.1158","volume":"79","author":[{"given":"Manjulata","family":"Singh","sequence":"first","affiliation":[{"name":"1Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Tian","sequence":"additional","affiliation":[{"name":"2Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania."},{"name":"3School of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3519-1938","authenticated-orcid":false,"given":"Vera S.","family":"Donnenberg","sequence":"additional","affiliation":[{"name":"1Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania."},{"name":"4Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine, McGowan Institute for Regenerative Medicine, and UPMC-Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0632-8296","authenticated-orcid":false,"given":"Alan M.","family":"Watson","sequence":"additional","affiliation":[{"name":"5Center for Biologic Imaging, Center for Vaccine Research, and Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JingYu","family":"Zhang","sequence":"additional","affiliation":[{"name":"2Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura P.","family":"Stabile","sequence":"additional","affiliation":[{"name":"6Department of Pharmacology & Chemical Biology, UPMC-Hillman Cancer Center, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Watkins","sequence":"additional","affiliation":[{"name":"7Center for Biologic Imaging and the Department of Cellular Biology, University of Pittsburgh, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3700-8765","authenticated-orcid":false,"given":"Jianhua","family":"Xing","sequence":"additional","affiliation":[{"name":"2Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania."},{"name":"8UPMC-Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2017-9584","authenticated-orcid":false,"given":"Shilpa","family":"Sant","sequence":"additional","affiliation":[{"name":"1Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania."},{"name":"8UPMC-Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania."},{"name":"9Department of Bioengineering, Swanson School of Engineering, and McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"key":"2022061706343458600_bib1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2022061706343458600_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aaf4405","article-title":"Hypoxic control of metastasis","volume":"352","author":"Rankin","year":"2016","journal-title":"Science"},{"key":"2022061706343458600_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"key":"2022061706343458600_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ceb.2014.07.003","article-title":"Illuminating breast cancer invasion: diverse roles for cell-cell interactions","volume":"30","author":"Cheung","year":"2014","journal-title":"Curr Opin Cell Biol"},{"key":"2022061706343458600_bib5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1158\/2159-8290.CD-15-0933","article-title":"Reduced proteolytic shedding of receptor tyrosine kinases is a post-translational mechanism of kinase inhibitor resistance","volume":"6","author":"Miller","year":"2016","journal-title":"Cancer Discov"},{"key":"2022061706343458600_bib6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.molonc.2010.09.001","article-title":"Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology","volume":"4","author":"Karagiannis","year":"2010","journal-title":"Mol Oncol"},{"key":"2022061706343458600_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature14492","article-title":"The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase","volume":"522","author":"Cox","year":"2015","journal-title":"Nature"},{"key":"2022061706343458600_bib8","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1158\/1078-0432.CCR-12-2747","article-title":"Monoclonal antibody against the ectodomain of E-cadherin (DECMA-1) suppresses breast carcinogenesis: involvement of the HER\/PI3K\/Akt\/mTOR and IAP pathways","volume":"19","author":"Brouxhon","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2022061706343458600_bib9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrc884","article-title":"Strategies for MMP inhibition in cancer: innovations for the post-trial era","volume":"2","author":"Overall","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2022061706343458600_bib10","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.bbapap.2013.03.014","article-title":"The secretome in cancer progression","volume":"1834","author":"Paltridge","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"2022061706343458600_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5020024","article-title":"Hypoxia, epithelial-mesenchymal transition, and TET-mediated epigenetic changes","volume":"5","author":"Kao","year":"2016","journal-title":"J Clin Med"},{"key":"2022061706343458600_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5050051","article-title":"Tumor budding: the name is EMT. Partial EMT","volume":"5","author":"Grigore","year":"2016","journal-title":"J Clin Med"},{"key":"2022061706343458600_bib13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.tcb.2018.06.008","article-title":"The different routes to metastasis via hypoxia-regulated programs","volume":"28","author":"Nobre","year":"2018","journal-title":"Trends Cell Biol"},{"key":"2022061706343458600_bib14","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bpj.2013.07.011","article-title":"Coupled reversible and irreversible bistable switches underlying TGFbeta-induced epithelial to mesenchymal transition","volume":"105","author":"Tian","year":"2013","journal-title":"Biophys J"},{"key":"2022061706343458600_bib15","doi-asserted-by":"crossref","first-page":"ra91","DOI":"10.1126\/scisignal.2005304","article-title":"TGF-beta-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops","volume":"7","author":"Zhang","year":"2014","journal-title":"Sci Signal"},{"key":"2022061706343458600_bib16","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1073\/pnas.85.24.9533","article-title":"Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells","volume":"85","author":"Young","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706343458600_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnci\/82.5.371","article-title":"Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential","volume":"82","author":"Young","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"2022061706343458600_bib18","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1200\/JCO.2008.17.0662","article-title":"Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003","volume":"26","author":"Mack","year":"2008","journal-title":"J Clin Oncol"},{"key":"2022061706343458600_bib19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.biotechadv.2016.04.005","article-title":"Hypoxic tumor microenvironment: opportunities to develop targeted therapies","volume":"34","author":"Patel","year":"2016","journal-title":"Biotechnol Adv"},{"key":"2022061706343458600_bib20","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1200\/JCO.2005.01.3771","article-title":"Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non\u2013small-cell lung cancer: Southwest Oncology Group Trial S0003","volume":"23","author":"Williamson","year":"2005","journal-title":"J Clin Oncol"},{"key":"2022061706343458600_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jcph.486","article-title":"Stem cell state and the epithelial-to-mesenchymal transition: implications for cancer therapy","volume":"55","author":"Donnenberg","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"2022061706343458600_bib22","doi-asserted-by":"crossref","first-page":"e0130348","DOI":"10.1371\/journal.pone.0130348","article-title":"Generation of multicellular tumor spheroids with microwell-based agarose scaffolds for drug testing","volume":"10","author":"Gong","year":"2015","journal-title":"PLoS One"},{"key":"2022061706343458600_bib23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/lt.20446","article-title":"Rapid, large-scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver","volume":"11","author":"Nyberg","year":"2005","journal-title":"Liver Transpl"},{"key":"2022061706343458600_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ddtec.2017.03.002","article-title":"The production of 3D tumor spheroids for cancer drug discovery","volume":"23","author":"Sant","year":"2017","journal-title":"Drug Discov Today Technol"},{"key":"2022061706343458600_bib25","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1158\/0008-5472.CAN-15-2304","article-title":"Three-dimensional breast cancer models mimic hallmarks of size-induced tumor progression","volume":"76","author":"Singh","year":"2016","journal-title":"Cancer Res"},{"key":"2022061706343458600_bib26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1089\/adt.2015.662","article-title":"Production of uniform 3D microtumors in hydrogel microwell arrays for measurement of viability, morphology, and signaling pathway activation","volume":"13","author":"Singh","year":"2015","journal-title":"Assay Drug Dev Technol"},{"key":"2022061706343458600_bib27","doi-asserted-by":"crossref","first-page":"9388","DOI":"10.1038\/s41598-018-27266-8","article-title":"Shift from stochastic to spatially-ordered expression of serine-glycine synthesis enzymes in 3D microtumors","volume":"8","author":"Singh","year":"2018","journal-title":"Sci Rep"},{"key":"2022061706343458600_bib28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1021\/acsbiomaterials.7b00081","article-title":"Controlled three-dimensional tumor microenvironments recapitulate phenotypic features and differential drug response in early vs. advanced stage breast cancer","volume":"4","author":"Singh","year":"2018","journal-title":"ACS Biomater Sci Eng"},{"key":"2022061706343458600_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/cyto.b.20530","article-title":"Localization of CD44 and CD90 positive cells to the invasive front of breast tumors","volume":"78","author":"Donnenberg","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"key":"2022061706343458600_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/cyto.a.22156","article-title":"Flow cytometric determination of stem\/progenitor content in epithelial tissues: an example from nonsmall lung cancer and normal lung","volume":"83","author":"Donnenberg","year":"2013","journal-title":"Cytometry A"},{"key":"2022061706343458600_bib31","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cell.2014.03.042","article-title":"Whole-brain imaging with single-cell resolution using chemical cocktails and computational analysis","volume":"157","author":"Susaki","year":"2014","journal-title":"Cell"},{"key":"2022061706343458600_bib32","doi-asserted-by":"crossref","first-page":"e0180486","DOI":"10.1371\/journal.pone.0180486","article-title":"Ribbon scanning confocal for high-speed high-resolution volume imaging of brain","volume":"12","author":"Watson","year":"2017","journal-title":"PLoS One"},{"key":"2022061706343458600_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-61779-452-0_15","article-title":"Use of gel zymography to examine matrix metalloproteinase (gelatinase) expression in brain tissue or in primary glial cultures","volume":"814","author":"Frankowski","year":"2012","journal-title":"Methods Mol Biol"},{"key":"2022061706343458600_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc2950","article-title":"What is the malignant nature of human ductal carcinoma in situ?","volume":"11","author":"Espina","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"2022061706343458600_bib35","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/embor.2013.92","article-title":"Cancer heterogeneity\u2013a multifaceted view","volume":"14","author":"De Sousa","year":"2013","journal-title":"EMBO Rep"},{"key":"2022061706343458600_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10585-017-9858-6","article-title":"Collective invasion in ductal and lobular breast cancer associates with distant metastasis","volume":"34","author":"Khalil","year":"2017","journal-title":"Clin Exp Metastasis"},{"key":"2022061706343458600_bib37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4048\/jbc.2011.14.2.88","article-title":"Overexpression of MMP-9 and HIF-1alpha in breast cancer cells under hypoxic conditions","volume":"14","author":"Choi","year":"2011","journal-title":"J Breast Cancer"},{"key":"2022061706343458600_bib38","doi-asserted-by":"crossref","first-page":"31277","DOI":"10.1074\/jbc.M110.158485","article-title":"Stabilization of hypoxia-inducible factor-1alpha protein in hypoxia occurs independently of mitochondrial reactive oxygen species production","volume":"285","author":"Chua","year":"2010","journal-title":"J Biol Chem"},{"key":"2022061706343458600_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/onc.2012.563","article-title":"Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K\/Akt\/mTOR signaling","volume":"33","author":"Brouxhon","year":"2014","journal-title":"Oncogene"},{"key":"2022061706343458600_bib40","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1158\/0008-5472.CAN-11-3498","article-title":"Dishonorable discharge: the oncogenic roles of cleaved E-cadherin fragments","volume":"72","author":"David","year":"2012","journal-title":"Cancer Res"},{"key":"2022061706343458600_bib41","doi-asserted-by":"crossref","first-page":"408047","DOI":"10.1155\/2014\/408047","article-title":"Levels of soluble E-cadherin in breast, gastric, and colorectal cancers","volume":"2014","author":"Repetto","year":"2014","journal-title":"BioMed Res Int"},{"key":"2022061706343458600_bib42","doi-asserted-by":"crossref","first-page":"18393","DOI":"10.1074\/jbc.M801329200","article-title":"The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation","volume":"283","author":"Najy","year":"2008","journal-title":"J Biol Chem"},{"key":"2022061706343458600_bib43","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.yexcr.2010.12.025","article-title":"Soluble E-cadherin promotes cell survival by activating epidermal growth factor receptor","volume":"317","author":"Inge","year":"2011","journal-title":"Exp Cell Res"},{"key":"2022061706343458600_bib44","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/mc.22048","article-title":"Soluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers","volume":"53","author":"Brouxhon","year":"2014","journal-title":"Mol Carcinog"},{"key":"2022061706343458600_bib45","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cellsig.2011.10.004","article-title":"EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cells","volume":"24","author":"Grabowska","year":"2012","journal-title":"Cell Signal"},{"key":"2022061706343458600_bib46","doi-asserted-by":"crossref","first-page":"C883","DOI":"10.1152\/ajpcell.00359.2005","article-title":"Regulation of homocysteine-induced MMP-9 by ERK1\/2 pathway","volume":"290","author":"Moshal","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"2022061706343458600_bib47","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1158\/1078-0432.CCR-16-0869","article-title":"Molecular pathways: receptor ectodomain shedding in treatment, resistance, and monitoring of cancer","volume":"23","author":"Miller","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2022061706343458600_bib48","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/jcph.765","article-title":"Precision oncology medicine: the clinical relevance of patient-specific biomarkers used to optimize cancer treatment","volume":"56","author":"Schmidt","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"2022061706343458600_bib49","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.2741\/4031","article-title":"Soluble E-cadherin: more than a symptom of disease","volume":"17","author":"Grabowska","year":"2012","journal-title":"Front Biosci"},{"key":"2022061706343458600_bib50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"key":"2022061706343458600_bib51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature16064","article-title":"Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer","volume":"527","author":"Zheng","year":"2015","journal-title":"Nature"},{"key":"2022061706343458600_bib52","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature15748","article-title":"Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance","volume":"527","author":"Fischer","year":"2015","journal-title":"Nature"},{"key":"2022061706343458600_bib53","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cell.2013.09.018","article-title":"The dynamics of signaling as a pharmacological target","volume":"155","author":"Behar","year":"2013","journal-title":"Cell"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/79\/11\/2962\/2777390\/2962.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/79\/11\/2962\/2777390\/2962.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T15:47:33Z","timestamp":1655480853000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/79\/11\/2962\/633180\/Targeting-the-Temporal-Dynamics-of-Hypoxia-Induced"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":53,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,6,3]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-18-3151","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6510800.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6510800","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22420982.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22420982","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22420979.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22420979","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]}}}